DK1093813T3 - Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk - Google Patents

Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk

Info

Publication number: DK1093813T3
Authority: DK; Denmark
Prior art keywords: coated; clavunalate; amoxycillin; film coating; polymeric film
Prior art date: 1994-04-23

Application number

DK00204182T

Other languages

English (en)

Inventor

Creighton Pierce Conley

Nigel Philip Mccreath Davidson

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-23

Filing date

1995-04-19

Publication date

2003-02-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1093813(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-04-19 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2003-02-17 Application granted granted Critical

2003-02-17 Publication of DK1093813T3 publication Critical patent/DK1093813T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK00204182T 1994-04-23 1995-04-19 Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk DK1093813T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9408117A GB9408117D0 (en)	1994-04-23	1994-04-23	Pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
DK1093813T3 true DK1093813T3 (da)	2003-02-17

Family

ID=10754044

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
DK99200891T DK0978276T3 (da)	1994-04-23	1995-04-19	Polymerovertrukken tablet omfattende amoxycillin og clavulanat
DK00204182T DK1093813T3 (da)	1994-04-23	1995-04-19	Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk
DK95917937T DK0758235T3 (da)	1994-04-23	1995-04-19	Polymercoatet tablet omfattende amoxycillin og clavulanat
DK96202848T DK0761218T3 (da)	1994-04-23	1995-04-19	Fremgangsmåde til fremstilling af polymerovertrukne tabletter omfattende amoxycillin og clavulanat

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK99200891T DK0978276T3 (da)	1994-04-23	1995-04-19	Polymerovertrukken tablet omfattende amoxycillin og clavulanat

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK95917937T DK0758235T3 (da)	1994-04-23	1995-04-19	Polymercoatet tablet omfattende amoxycillin og clavulanat
DK96202848T DK0761218T3 (da)	1994-04-23	1995-04-19	Fremgangsmåde til fremstilling af polymerovertrukne tabletter omfattende amoxycillin og clavulanat

Country Status (35)

Country	Link
US (1)	US6051255A (da)
EP (5)	EP0978276B1 (da)
JP (1)	JP3622975B2 (da)
CN (1)	CN1134258C (da)
AP (2)	AP564A (da)
AT (6)	ATE226074T1 (da)
AU (1)	AU684949B2 (da)
BG (1)	BG62842B1 (da)
BR (1)	BR9507502A (da)
CA (1)	CA2188496A1 (da)
CZ (2)	CZ294168B6 (da)
DE (5)	DE29522153U1 (da)
DK (4)	DK0978276T3 (da)
DZ (1)	DZ1876A1 (da)
ES (4)	ES2180251T3 (da)
FI (1)	FI964249A7 (da)
GB (1)	GB9408117D0 (da)
GR (2)	GR3035031T3 (da)
HK (1)	HK1050992A1 (da)
HU (1)	HU228399B1 (da)
IL (1)	IL113433A (da)
MA (1)	MA23528A1 (da)
MY (1)	MY115351A (da)
NO (1)	NO310703B1 (da)
NZ (1)	NZ285080A (da)
OA (1)	OA10377A (da)
PL (1)	PL316966A1 (da)
PT (4)	PT761218E (da)
RO (1)	RO116997B1 (da)
RU (1)	RU2152213C1 (da)
SA (1)	SA95160343B1 (da)
SI (1)	SI0758235T1 (da)
SK (1)	SK282594B6 (da)
WO (1)	WO1995028927A1 (da)
ZA (1)	ZA953236B (da)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9407386D0 (en)	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
DZ2028A1 (fr) *	1995-05-03	2002-10-23	Smithkline Beecham Plc	Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) *	1995-06-06	2003-06-12	Smithkline Beecham P.L.C.	Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
ATE208618T1 (de)	1995-09-07	2001-11-15	Smithkline Beecham Corp	Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
AT403375B (de) *	1995-11-15	1998-01-26	Biochemie Gmbh	Verfahren zur fällung von alkalisalzen der clavulansäure
TWI225402B (en) *	1996-03-13	2004-12-21	Biochemie Gmbh	Auxiliary-free agglomerates
AT407701B (de) *	1996-08-12	2001-05-25	Biochemie Gmbh	Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
GB9613470D0 (en)	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
GB9616536D0 (en)	1996-08-06	1996-09-25	Quadrant Holdings Cambridge	Co-amoxiclav dosage form
GB9617780D0 (en)	1996-08-24	1996-10-02	Smithkline Beecham Plc	Method of treatment
AU6496498A (en) *	1997-02-07	1998-08-26	Gist-Brocades B.V.	Homogeneous granulated formulations for dose sipping technology
SK110299A3 (en) *	1997-02-14	2000-08-14	Smithkline Beecham Lab	Pharmaceutical formulations comprising amoxocyllin and clavulanate, preparation method and use thereof
US20030124187A1 (en) *	1997-02-14	2003-07-03	Smithkline Beecham Laboratoires Pharmaceutiques,	Pharmaceutical formulations comprising amoxycillin and clavulanate
WO1999011261A1 (en) *	1997-08-29	1999-03-11	Dsm N.V.	Granules free of excipients
CA2307887A1 (en)	1997-10-31	1999-05-14	Monsanto Company	Gellan gum tablet coating
DE60008508T9 (de)	1999-04-01	2012-06-14	Dsm Ip Assets B.V.	Agglomerate durch kristallisation
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) *	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) *	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
AU767177B2 (en) *	1999-04-13	2003-11-06	Beecham Pharmaceuticals (Pte) Limited	Novel method of treatment
US20040038948A1 (en) *	1999-12-07	2004-02-26	Uhrich Kathryn E.	Therapeutic compositions and methods
GB9930578D0 (en) *	1999-12-23	2000-02-16	Smithkline Beecham Plc	Pharmaceutical formulations
US6565882B2 (en) *	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6375982B1 (en) *	2000-07-05	2002-04-23	Capricorn Pharma, Inc.	Rapid-melt semi-solid compositions, methods of making same and method of using same
AU2001279284A1 (en) *	2000-07-05	2002-01-14	Capricorn Pharma, Inc	Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001292185A1 (en) *	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US6756057B2 (en) *	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
US6541014B2 (en) *	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020068078A1 (en) *	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US20020197314A1 (en) *	2001-02-23	2002-12-26	Rudnic Edward M.	Anti-fungal composition
JP5328071B2 (ja) *	2001-04-10	2013-10-30	サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド	時限パルス放出組成物
US20030070584A1 (en) *	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
AU4061702A (en) *	2001-05-15	2003-04-03	Mcneil-Ppc, Inc.	Dip coating compositions containing starch or dextrin
US8309118B2 (en) *	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
WO2003066053A1 (en) *	2002-02-07	2003-08-14	Rutgers, The State University	Antibiotic polymers
KR100967782B1 (ko) *	2002-02-14	2010-07-05	글락소 그룹 리미티드	Ｎ-((1-Ｎ-부틸-4-피페리디닐)메틸)-3,4-디하이드로-2Ｈ-(1,3)옥사지노(3,2-ａ)인돌-10-카복스아미드 또는 그의 염을포함하는 제약 조성물, 및 건식 과립화를 포함하는 그의제조 방법
GB0203528D0 (en) *	2002-02-14	2002-04-03	Glaxo Group Ltd	Process and composition
US20060083759A1 (en) *	2002-07-17	2006-04-20	Aleksander Resman	Stabilization of the profile of release of active substances from a formulation
US8637512B2 (en)	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
KR100456833B1 (ko) *	2002-08-01	2004-11-10	주식회사 대웅	아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) *	2002-08-02	2008-09-30	Mcneil Consumer Healthcare	Polyacrylic film forming compositions
CA2406592C (en) *	2002-10-04	2003-09-30	Duchesnay Inc.	Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7405210B2 (en)	2003-05-21	2008-07-29	Osi Pharmaceuticals, Inc.	Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
JP2006528190A (ja)	2003-07-21	2006-12-14	アドバンシスファーマスーティカルコーポレイション	抗生物質製剤、その使用法及び作成方法
US8313776B2 (en) *	2003-07-21	2012-11-20	Shionogi Inc.	Antibiotic product, use and formulation thereof
CA2533358C (en) *	2003-07-21	2014-03-11	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
AU2004264939A1 (en) *	2003-08-11	2005-02-24	Middlebrook Pharmaceuticals, Inc.	Robust pellet
JP2007502294A (ja) *	2003-08-12	2007-02-08	アドバンシスファーマスーティカルコーポレイション	抗生物質製剤、その使用法及び作成方法
WO2005023184A2 (en) *	2003-08-29	2005-03-17	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
DE10341264A1 (de) *	2003-09-04	2005-03-24	Grünenthal GmbH	Schmelzformulierte, multipartikuläre orale Darreichungsform
EP1663169A4 (en) *	2003-09-15	2010-11-24	Middlebrook Pharmaceuticals In	ANTIBIOTICS, ITS USE AND FORMULATION
US20050142187A1 (en) *	2003-12-24	2005-06-30	Treacy Donald J.Jr.	Enhanced absorption of modified release dosage forms
DE602005023965D1 (de)	2004-03-08	2010-11-18	Prosidion Ltd	Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
JP2008505124A (ja) *	2004-07-02	2008-02-21	アドバンシスファーマスーティカルコーポレイション	パルス送達用錠剤
KR100638315B1 (ko) *	2004-07-23	2006-10-25	주식회사 대웅제약	다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
JP5000491B2 (ja)	2005-05-20	2012-08-15	第一三共株式会社	フィルムコーティング製剤
KR100780553B1 (ko) *	2005-08-18	2007-11-29	한올제약주식회사	메트포르민 서방정 및 그의 제조방법
US8778924B2 (en) *	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en)	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) *	2007-11-01	2009-11-27	Sanofi Aventis Healthcare Pty Ltd	Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
RU2012115459A (ru) *	2009-09-18	2013-10-27	Санофи	Таблетируюмый препарат (4'-трифторметилфенил)амида (z)-2-циано-3-гидрокси-бут-2-еноевой кислоты с улучшенной устойчивостью
TR200909787A2 (tr)	2009-12-25	2011-07-21	Bi̇lgi̇ç Mahmut	Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000687A1 (tr)	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
JP6041591B2 (ja) *	2011-09-13	2016-12-14	大日本住友製薬株式会社	イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en)	2013-03-15	2016-07-12	Rutgers, The State University Of New Jersey	Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1241844A (en)	1968-08-23	1971-08-04	Beecham Group Ltd	Penicillins
GB1508977A (en)	1974-04-20	1978-04-26	Beecham Group Ltd	Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) *	1975-04-14	1978-07-04	Beecham Group Limited	Anti bacterial agents
JO984B1 (en) *	1977-10-11	1979-12-01	بيتشام غروب ليمتد	A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) *	1980-09-27	1983-12-16	Beecham Group Ltd	Tablet containing amoxycillin and potassium clavulanate
DE3266580D1 (en) *	1981-12-02	1985-10-31	Beecham Group Plc	Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
AU767177B2 (en) *	1999-04-13	2003-11-06	Beecham Pharmaceuticals (Pte) Limited	Novel method of treatment
AU2001292185A1 (en) *	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin

1994
- 1994-04-23 GB GB9408117A patent/GB9408117D0/en active Pending
1995
- 1995-04-13 AP APAP/P/1995/000733A patent/AP564A/en active
- 1995-04-19 SI SI9530526T patent/SI0758235T1/xx unknown
- 1995-04-19 PT PT96202848T patent/PT761218E/pt unknown
- 1995-04-19 AT AT00204182T patent/ATE226074T1/de not_active IP Right Cessation
- 1995-04-19 WO PCT/EP1995/001463 patent/WO1995028927A1/en not_active Ceased
- 1995-04-19 DE DE29522153U patent/DE29522153U1/de not_active Expired - Lifetime
- 1995-04-19 DK DK99200891T patent/DK0978276T3/da active
- 1995-04-19 RU RU96122474/14A patent/RU2152213C1/ru active
- 1995-04-19 DE DE69528204T patent/DE69528204T2/de not_active Expired - Lifetime
- 1995-04-19 ES ES99200891T patent/ES2180251T3/es not_active Expired - Lifetime
- 1995-04-19 ES ES95917937T patent/ES2161288T3/es not_active Expired - Lifetime
- 1995-04-19 CZ CZ19963090A patent/CZ294168B6/cs not_active IP Right Cessation
- 1995-04-19 DK DK00204182T patent/DK1093813T3/da active
- 1995-04-19 ES ES00204182T patent/ES2182754T3/es not_active Expired - Lifetime
- 1995-04-19 CZ CZ200011418U patent/CZ11376U1/cs not_active IP Right Cessation
- 1995-04-19 JP JP52733495A patent/JP3622975B2/ja not_active Expired - Lifetime
- 1995-04-19 DK DK95917937T patent/DK0758235T3/da active
- 1995-04-19 SK SK1354-96A patent/SK282594B6/sk not_active IP Right Cessation
- 1995-04-19 AT AT95917937T patent/ATE203161T1/de active
- 1995-04-19 FI FI964249A patent/FI964249A7/fi not_active Application Discontinuation
- 1995-04-19 BR BR9507502A patent/BR9507502A/pt not_active IP Right Cessation
- 1995-04-19 DE DE69528608T patent/DE69528608T2/de not_active Revoked
- 1995-04-19 CA CA002188496A patent/CA2188496A1/en not_active Abandoned
- 1995-04-19 ES ES96202848T patent/ES2152485T3/es not_active Expired - Lifetime
- 1995-04-19 AT AT96202848T patent/ATE196845T1/de not_active IP Right Cessation
- 1995-04-19 HU HU9602922A patent/HU228399B1/hu unknown
- 1995-04-19 EP EP99200891A patent/EP0978276B1/en not_active Expired - Lifetime
- 1995-04-19 AT AT99200891T patent/ATE223706T1/de active
- 1995-04-19 PT PT95917937T patent/PT758235E/pt unknown
- 1995-04-19 PL PL95316966A patent/PL316966A1/xx unknown
- 1995-04-19 DK DK96202848T patent/DK0761218T3/da active
- 1995-04-19 DE DE69521799T patent/DE69521799T2/de not_active Expired - Lifetime
- 1995-04-19 RO RO96-02030A patent/RO116997B1/ro unknown
- 1995-04-19 DE DE69519093T patent/DE69519093T2/de not_active Expired - Fee Related
- 1995-04-19 NZ NZ285080A patent/NZ285080A/en not_active IP Right Cessation
- 1995-04-19 EP EP96202848A patent/EP0761218B1/en not_active Revoked
- 1995-04-19 EP EP95917937A patent/EP0758235B1/en not_active Expired - Lifetime
- 1995-04-19 PT PT99200891T patent/PT978276E/pt unknown
- 1995-04-19 EP EP00204182A patent/EP1093813B1/en not_active Revoked
- 1995-04-19 CN CNB951934023A patent/CN1134258C/zh not_active Expired - Lifetime
- 1995-04-19 EP EP02076874A patent/EP1243267A3/en not_active Withdrawn
- 1995-04-19 PT PT00204182T patent/PT1093813E/pt unknown
- 1995-04-19 US US08/727,581 patent/US6051255A/en not_active Expired - Lifetime
- 1995-04-19 AP APAP/P/1996/000868A patent/AP9600868A0/en unknown
- 1995-04-19 AU AU24068/95A patent/AU684949B2/en not_active Expired
- 1995-04-20 IL IL11343395A patent/IL113433A/xx unknown
- 1995-04-20 MY MYPI95001037A patent/MY115351A/en unknown
- 1995-04-21 MA MA23858A patent/MA23528A1/fr unknown
- 1995-04-21 ZA ZA953236A patent/ZA953236B/xx unknown
- 1995-04-22 DZ DZ950044A patent/DZ1876A1/fr active
- 1995-10-25 SA SA95160343A patent/SA95160343B1/ar unknown
1996
- 1996-10-22 NO NO19964488A patent/NO310703B1/no not_active IP Right Cessation
- 1996-10-23 OA OA60908A patent/OA10377A/en unknown
- 1996-10-23 BG BG100933A patent/BG62842B1/bg unknown
1998
- 1998-09-21 HK HK03101681.9A patent/HK1050992A1/en unknown
2000
- 2000-07-18 AT AT0052400U patent/AT5349U1/de not_active IP Right Cessation
- 2000-12-12 GR GR20000402718T patent/GR3035031T3/el not_active IP Right Cessation
2001
- 2001-04-11 AT AT0028501U patent/AT5350U1/de not_active IP Right Cessation
- 2001-10-09 GR GR20010401708T patent/GR3036844T3/el unknown

Also Published As

Publication number	Publication date
EP1243267A3 (en)	2002-10-30
ATE203161T1 (de)	2001-08-15
ES2182754T3 (es)	2003-03-16
DK0761218T3 (da)	2000-12-18
EP0761218A1 (en)	1997-03-12
DK0978276T3 (da)	2003-01-20
ATE226074T1 (de)	2002-11-15
DE29522153U1 (de)	2000-04-06
DE69528204T2 (de)	2003-08-07
CZ294168B6 (cs)	2004-10-13
HU9602922D0 (en)	1996-12-30
HK1021860A1 (en)	2000-07-07
OA10377A (en)	2001-11-21
FI964249L (fi)	1996-10-22
US6051255A (en)	2000-04-18
MY115351A (en)	2003-05-31
HK1036404A1 (en)	2002-01-04
DE69528204D1 (de)	2002-10-17
PT1093813E (pt)	2003-02-28
GR3035031T3 (en)	2001-03-30
DE69519093D1 (de)	2000-11-16
FI964249A0 (fi)	1996-10-22
AP9600868A0 (en)	1996-10-31
DE69528608D1 (de)	2002-11-21
EP1093813B1 (en)	2002-10-16
CZ11376U1 (cs)	2001-07-12
EP0978276A2 (en)	2000-02-09
PT758235E (pt)	2001-10-31
CN1134258C (zh)	2004-01-14
HK1009936A1 (en)	1999-06-11
AT5350U1 (de)	2002-06-25
IL113433A0 (en)	1995-07-31
AT5349U1 (de)	2002-06-25
NO964488L (no)	1996-12-17
GB9408117D0 (en)	1994-06-15
EP1093813A2 (en)	2001-04-25
NZ285080A (en)	1998-05-27
ZA953236B (en)	1995-12-27
HK1050992A1 (en)	2003-07-18
JP3622975B2 (ja)	2005-02-23
FI964249A7 (fi)	1996-10-22
NO310703B1 (no)	2001-08-20
ES2161288T3 (es)	2001-12-01
HUT76335A (en)	1997-08-28
SI0758235T1 (en)	2001-10-31
RU2152213C1 (ru)	2000-07-10
DE69521799D1 (de)	2001-08-23
PT978276E (pt)	2003-01-31
HU228399B1 (en)	2013-03-28
AU684949B2 (en)	1998-01-08
EP0758235B1 (en)	2001-07-18
ATE196845T1 (de)	2000-10-15
EP0978276A3 (en)	2000-04-12
CZ309096A3 (en)	1997-04-16
SK135496A3 (en)	1997-05-07
BG62842B1 (bg)	2000-09-29
SK282594B6 (sk)	2002-10-08
EP0761218B1 (en)	2000-10-11
EP0758235A1 (en)	1997-02-19
GR3036844T3 (en)	2002-01-31
PL316966A1 (en)	1997-03-03
CA2188496A1 (en)	1995-11-02
DE69528608T2 (de)	2003-06-26
JPH09512027A (ja)	1997-12-02
BR9507502A (pt)	1997-09-02
ES2180251T3 (es)	2003-02-01
AP9500733A0 (en)	1995-04-30
SA95160343B1 (ar)	2005-05-04
DE69521799T2 (de)	2002-06-13
WO1995028927A1 (en)	1995-11-02
NO964488D0 (no)	1996-10-22
DK0758235T3 (da)	2001-10-29
DE69519093T2 (de)	2001-07-19
MA23528A1 (fr)	1995-12-31
HK1027024A1 (en)	2001-01-05
AU2406895A (en)	1995-11-16
IL113433A (en)	2003-06-24
CN1149829A (zh)	1997-05-14
RO116997B1 (ro)	2001-09-28
AP564A (en)	1996-11-21
DZ1876A1 (fr)	2002-02-17
ES2152485T3 (es)	2001-02-01
PT761218E (pt)	2001-03-30
EP1093813A3 (en)	2001-05-30
ATE223706T1 (de)	2002-09-15
BG100933A (en)	1997-07-31
EP1243267A2 (en)	2002-09-25
EP0978276B1 (en)	2002-09-11

Publication	Publication Date	Title
DK1093813T3 (da)	2003-02-17	Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk
DE69016433D1 (de)	1995-03-09	Beschichtungsverfahren und -vorrichtung.
NO894864L (no)	1990-07-06	Belagt forglasseringsmateriale og fremgangsmaate for belegging av dette.
IL104248A0 (en)	1993-05-13	Energy-polymerizable adhesive,coating,film and process for making the same
FI844659A7 (fi)	1985-05-29	Muovipäällyksellä varustetut säiliöt, niitä varten tarkoitetut muovipäällykset ja menetelmä päällysten asettamiseksi.
NO894865D0 (no)	1989-12-05	Belagt glasseringsmateriale og fremgangsmaate for belegging av dette.
NL1001008C2 (nl)	1996-12-24	Bekleed substraat en werkwijze voor de vorming ervan.
EP0618504A3 (en)	1996-04-10	Method and device for applying a film.
FI944171A7 (fi)	1995-03-14	Substraattien päällystykseen soveltuvia tahnoja, manetelmä niiden valmistamiseksi sekä niiden käyttö
DE69612216D1 (de)	2001-04-26	Metallblech mit rostpreventiver organischer beschichtung, verfahren zu dessen herstellung und behandlungsflüssigkeit dafür
FI844660A7 (fi)	1985-05-29	Kiinteällä muovipäällyksellä varustetut säiliöt, niitä varten tarkoitetut muovipäällykset ja menetelmä päällysten asettamiseksi.
DE69506854D1 (de)	1999-02-04	Härtbare harzzusammensetzung, beschichtungszusammensetzung, beschichtungsmethode und beschichteter gegenstand
DK0633070T3 (da)	1998-05-25	Fremgangsmåde til pulvercoating til emner
BR9711032B1 (pt)	2008-11-18	comprimido de maleato de trimebutina revestido com pelÍcula e processo de preparo do mesmo.
FI940129A7 (fi)	1994-07-13	Menetelmä ja laite gelatiinipäällystyksen aikaansaamiseksi
FI960560L (fi)	1997-08-08	Menetelmä filminsiirtopäällystyksessä ja menetelmän toteuttamiseen tarkoitettu laitteisto
FI912692A7 (fi)	1991-12-09	Paperinpäällystysmenetelmä ja -laite
DE69521465D1 (de)	2001-08-02	Benzisoselen-azoline und-azine-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung
IT9047538A0 (it)	1990-01-17	Prodotto rivestito e metodo per rivestirlo.
NO941997D0 (no)	1994-05-30	Fremgangsmåte for belegging av fröplante og system for fremgangsmåtens utförelse
DE69504488D1 (de)	1998-10-08	Härtbare harz- und beschichtungs-zusammensetzung, beschichtungsverfahren und beschichteter gegenstand
UA1670S (uk)	1997-12-25	Прилад для нанесення фарбувальних, клейких, коректувальних та інших рідин
MX9205742A (es)	1993-04-01	Metodo y aparato para aplicar un revestimiento, auxiliado ultrasonicamente.
FI950338L (fi)	1995-01-26	Menetelmä pinnoituspaksuuden mittaamiseksi paperia pinnoitettaessa, menettely menetelmän suorittamiseksi, ja laitteiston käyttö
AU1861095A (en)	1995-09-18	Coating composition, process for forming cured film and coated article